Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 1 of the 13 calendar months from Oct 2025 to Oct 2026: Oct 2025.
- Largest single sale: $7.3M (111,755 shares) of BridgeBio Pharma, Inc. on Oct 29, 2025. Filing
- Last sale before this period: Sep 5, 2025.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| BridgeBio Pharma, Inc. (BBIO) | Director | Jun 27, 2019 | Jun 24, 2026 |
Recent filings
The last 3 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Jun 22, 2026, BridgeBio Pharma, Inc.: 3,990 shares granted. 1 filing: 1
- Oct 29, 2025, BridgeBio Pharma, Inc.: sold 198,359 shares for $13.2M, under a disclosed plan (some held indirectly). 1 filing: 1
- Oct 27, 2025, BridgeBio Pharma, Inc.: sold 1,641 shares for $107K, under a disclosed plan (some held indirectly). 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.